A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation

Saulius K. Girnius, Saem Lee, Suman Kambhampati, Michal G. Rose, Abid Mohiuddin, Antoun Houranieh, Abraham Zimelman, Terrence Grady, Paulette Mehta, Caroline Behler, Teresa G. Hayes, Yvonne A. Efebera, Rao H. Prabhala, Andrew Han, Sarvari V. Yellapragada, Catherine E. Klein, Garson D. Roodman, Alan Lichtenstein, Nikhil C. Munshi

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences